Some previous studies in children have demonstrated improved specificities achieved by combining both protein and glycolipid antigens within serological assays [26 (link)–29 (link)]. Furthermore, several studies have illuminated the potential for heightened sensitivity through the combined analysis of multiple antigen targets, effectively overcoming the interindividual heterogeneity of the human humoral immune response to M. tuberculosis [26 (link)–33 (link)].
We will analyse antibodies concentrations and properties against single protein antigens, single glycolipid antigens [12 (link), 34 (link)–40 (link)], as well as multiple antigens in combination (Table 2). The types of antigens include cell wall fractions, whole cell lysates, and total lipids of M. tuberculosis. The selection of protein antigens is based on results from large protein microarray studies in adults [41 (link)–46 (link)], one large multiplex bead-based study in children [31 (link)], and published and unpublished data from an adult study performed in the U.K (MIMIC study; personal communication M. Tebruegge) [47 ]. In order to enhance specificity, the overlap of the antigen targets for M. tuberculosis with Bacillus Calmette-Guérin (BCG) and other non-tuberculous mycobacteria will be reduced.

Key protein, glycolipid, and multiple antigens

TypeNameRv number/Full name
ProteinFbpC (Ag85C)Rv0129c
PstS3Rv0928
PstS1Rv0934
PapA4Rv1528
GarARv1827
Apa (Mpt32)Rv1860
FbpB (Ag85B)Rv1886c
Mpt63Rv1926c
Mpt64Rv1980c
HspX (Acr)Rv2031c
AcgRv2032
Rv2034Rv2034
Hrp1Rv2626c
EsxO-EsxPRv2346-Rv2347
EspARv3616c
FbpD (Mpt51)Rv3803c
FbpA (Ag85A)Rv3804c
EsxB (CFP-10)Rv3874
EsxA (ESAT-6)Rv3875
EsxA-EsxB (ESAT6-CFP10)Rv3875-Rv3874
EspD-EspCRv3614-Rv3615
EspBRV3881c
Ag85 complexRv3804c-Rv1886c-Rv0129c
GlycolipidLAMLipoarabinomannan
PDIMPhthiocerol dimycocerosates
TDMTrehalose dimycolates
TMMTrehalose monomycolates
PGLPhenolic glycolipid
Multiple antigens (H37Rv)Cell wall fractionscontains proteins and non-protein compounds such as mAGP of M. tuberculosis
Cell membrane fractionscontains the cytoplasmic membrane and components of the outer lipid layer.
Whole cell lysatescontains proteins, lipids and carbohydrates present within the M. tuberculosis bacterial cell
Total hypoxic lipidscontaining hypoxic culture M. tuberculosis
Total normoxic lipidscontaining normoxic culture M. tuberculosis

Abbreviations: Acg - alpha-crystallin homolog -coregulated gene; Acr - alpha-crystallin homolog; Ag85 complex - antigen 85 complex; Apa - alanine and proline rich secreted protein; CFP-10 - culture filtrate protein-10; ESAT-6 - early secreted antigenic target-6; EspA - ESX-1 secretion-associated protein A; EsxA/B/C/D/O/P - early secretory antigenic target homolog A/B/C/D/O/P; FbpA/B/C/D - fibronectin binding protein A/B/C/D; GarA - Glycogen accumulation regulator A; Hrp1 - hypoxic response protein 1; HspX - heat shock protein-X; Mpt32/51/63/64 - Proteins purified from Mycobacterium tuberculosis 32/51/63/64; PapA4 - polyketide synthase (PKS) associated protein; PstS1/3 - periplasmic phosphate-binding lipoprotein S1/3

Together with targeted M. tuberculosis antigens, this study will evaluate the following distinct properties of the antibodies: isotypes and their subclasses, FcR binding profiles, and antibody glycosylation patterns (refer to Fig. 1). The rational for this is to obtain further information about the immune response to the antigen. TB disease results from a combination of the mycobacteria infecting and the resulting pathologic immune response. Therefore, antibody concentrations may only reflect on exposure, timepoint, and burden of mycobacteria, whereas additional properties such as FcR may reflect on the fact if the immune response producing tissue damage and pathology or not. This is shown in studies in children with TB disease that have demonstrated the potential enhancement of serological assay sensitivity through the integration of diverse antibody isotypes [48 (link)–50 (link)]. Recent advancements in adult research have indicated that an evaluation of certain antibody properties, such as FcRs binding profiles and glycosylation patterns, could potentially enable the differentiation between TB disease and infection [12 (link), 13 (link)].

Overview of the antibody properties

Interaction between the surface of M. tuberculosis, binding of the antibody and the recognition of the antibody by an immune cell. Sections A, B, and C detail the different antibody properties: A) antibody isotypes and IgG subclasses B) glycosylation patterns of antibodies, including a core glycan and potential additional sugar residues (1–4) C) activating and inhibiting FcRs with varying affinities for antibody binding

Abbreviations: Mtb -Mycobacterium tuberculosis; FcR -fragmented crystallizable region (Fc) receptor; IgM - immunoglobulin M; IgD - immunoglobulin D, IgG1 − 4 - immunoglobulin G1 − 4; IgA - immunoglobulin A, N - N-acetylglucosamine; M - mannose; G - galactose; S - sialic acid; F - fucose

As a quality control and potential normalisation variable, we will measure the total antibody concentration of each isotype and the total antibody concentration binding to distinct FcRs.
Free full text: Click here